Related Experiment Video
Updated: Jun 25, 2026

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
Automated Pharmacometric Model Development by Leveraging Low-Dimensional Neural ODEs and LASSO Regression
Dominic Stefan Bräm1, Bernhard Steiert2, Britta Steffens1
1Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel UKBB, Basel, Switzerland.
This study introduces an automated approach combining neural ordinary differential equations (NODEs) and LASSO regression to develop interpretable pharmacokinetic/pharmacodynamic (PK/PD) models, reducing manual effort in pharmacometrics (PMX). The NODE-LASSO method efficiently generates mechanism-based structures from data, enhancing model-informed drug development.
Area of Science:
- Pharmacometrics
- Machine Learning
- Pharmacokinetics/Pharmacodynamics
Background:
- Current pharmacometrics (PMX) model development is manual, iterative, and resource-intensive.
- Existing automated methods still rely on iterative processes and goodness-of-fit criteria for model selection.
- Neural ordinary differential equations (NODEs) show potential for complex PK/PD dynamics but lack interpretability.
Purpose of the Study:
- To develop an automated approach for generating interpretable structural models in pharmacometrics.
- To combine the data-driven capabilities of NODEs with the interpretability of mechanistic models.
- To reduce the manual effort and time required for pharmacometric model development.
Main Methods:
- Integration of neural ordinary differential equations (NODEs) with least absolute shrinkage and selection operator (LASSO) regression.
- Leveraging LASSO's feature selection to automatically propose structural models based on NODE-learned dynamics.
- Application and validation of the NODE-LASSO approach on neonatal weight, bi-exponential PK, and warfarin PK/PD data.
Main Results:
- The automated NODE-LASSO approach successfully recovered meaningful, mechanism-based structures from data.
- Demonstrated applicability across diverse scenarios including physiological and drug-specific PK/PD.
- Significantly reduced the need for extensive iterative and manual model development.
Conclusions:
- The NODE-LASSO approach offers a resource-efficient and interpretable modeling strategy for pharmacometrics.
- This method has strong potential for application in model-informed drug development and clinical research.
- Automating the proposal of mechanistic structures enhances the utility of data-driven models in PMX.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Pharmacodynamic Models: Overview
Mechanistic Models: Compartment Models in Individual and Population Analysis